Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Toxicology

Fentanyl

Fentanyl

Serum fentanyl concentrations attain a range of 0.3 – 1.2 µg/L within 24 hours after application of a 25 µg/hr transdermal patch with serum levels inceasing up to 3.8 µg/L with use of a 100 µg/hr patch. (Baselt, Disposition of Toxic Drugs and Chemicals in Man, Eighth Edition, 2008). 

Fluoxetine

Fluoxetine

Therapeutic range = 120 - 500 ug/L (sum of fluoxetine and desmethylfluoxetine)

Gabapentin (Neurontin)

Gabapentin (Neurontin)

Therapeutic monitoring of gabapentin is not recommended. It may accumulate in renal failure.

Therapeutic range: 2 – 20 mg/L.

(Source: Therapeutic Drug Monitoring in Laboratory Medicine. Hallworth & Watson)

Gamma hydroxybutyrate (GHB)

Gamma hydroxybutyrate (GHB)

Gamma-hydroxybutyrate (GHB) has been employed as an anaesthetic agent but is now more widely used and abused for its sedative properties. Toxic effects (euphoria, dizziness and unconsciousness) usually occur around 15 minutes post ingestion and last on average for about 3 hours. It has been found that blood concentrations above 260 mg/L were associated with deep sleep, 156 – 260 mg/L with moderate sleep, 52 – 156 mg/L with light sleep and levels less than 52 mg/L with wakefulness.

 

Gamma hydroxybutyrate (GHB)

Gamma hydroxybutyrate (GHB)

Gamma-hydroxybutyrate (GHB) has been employed as an anaesthetic agent but is now more widely used and abused for its sedative properties. Toxic effects (euphoria, dizziness and unconsciousness) usually occur around 15 minutes post ingestion and last on average for about 3 hours. It has been found that blood concentrations above 260 mg/L were associated with deep sleep, 156 – 260 mg/L with moderate sleep, 52 – 156 mg/L with light sleep and levels less than 52 mg/L with wakefulness.

 

Imipramine and Desipramine

Imipramine and Desipramine

Therapeutic range between 175 and 300 ug/L (total sum of imipramine and desipramine)

For patients on desipramine (Norpramin) therapeutic range between 100 to 300 ug/L (desipramine only)

Ketamine

Ketamine

Therapeutic use of ketamine (i.v) for sedation is effective at average concentrations >0.6 mg/L. (Clarke's Analysis of Drugs & Poisons, Third Edition)

Lamotrigine (Lamictal)

Lamotrigine (Lamictal)

Therapeutic range (epilepsy): 1 - 4 mg/L

Maximum drug efficacy (bipolar disorder): 3 - 14 mg/L

Lead

Lead

Normal values: <0.24 umol/L

Desirable values in children: <0.24 umol/L

Occupational Certification Limit for women of reproductive capacity: 1.45 umol/L

Occupational Certification Limit for males (age 18+): 2.90 umol/L

INDUSTRIAL EXPOSURE

 

Repeat within 12 months

< 1.4

Repeat within 6 months

> 1.4 – 1.9

Repeat within 3 months

> 1.9 – 2.4

Repeat within 3 months

> 2.4 – 2.9

At doctors discretion but not more than 3 months

> 2.9

Please note that the normal values have been decreased as of 2018 to bring us in-line with CDC recommendations.

Levetiracetam (Keppra)

Levetiracetam (Keppra)

There is no evidence to justify monitoring of Levetiracetam other than to assess adherence, though a range of 6 – 20 mg/L has been suggested. Renal excretion means that the plasma half-life is longer in the elderly. Dose reduction is necessary at GFR < 60 mL/min/1.73 m2.

Levetiracetam (Keppra)

Levetiracetam (Keppra)

There is no evidence to justify monitoring of Levetiracetam other than to assess adherence, though a range of 6 – 20 mg/L has been suggested. Renal excretion means that the plasma half-life is longer in the elderly. Dose reduction is necessary at GFR < 60 mL/min/1.73 m2.

Lorazepam

Lorazepam

0.02 - 0.25 mg/L

Lorazepam

Lorazepam

0.02 - 0.25 mg/L

Manganese (Whole Blood)

Manganese (Whole Blood)

Manganese (MN)

nmol/L

Normal Values

80-260

Risk of Toxicity

> 360

Source: SAS Trace Element Laboratories Update, 2018

MDMA & MDA

MDMA & MDA

Toxicity associated with MDMA levels > 0.35 mg/L & MDA levels > 1.5 mg/L.  (Schulz et al. Critical Care 2012, 16:R136).

Melphalan (Alkeran)

Melphalan (Alkeran)

No reference range available. 

Melphalan (Alkeran)

Melphalan (Alkeran)

No reference range available. 

Methadone

Methadone

Therapeutic use of methadone is typically associated with plasma concentrations of 0.05 to 1.0 mg/L dependent on the dose, with adverse drug reactions being noted in the region of 1 to 2 mg/L for regular users of the drug. (Clarke's Analysis of Drugs & Poisons, Third Edition). 

<<  1 [23 4  >>